Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Option and Sells Shares

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on March 26, 2025, according to a Form 4 filing with the SEC.

Summary

• Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., executed a stock option to acquire 67,687 shares of Class A Common Stock at a price of $0.40 on March 26, 2025.
• Concurrently, Baird sold a total of 67,687 shares of Class A Common Stock in multiple transactions at prices ranging from $33.5709 to $37.3542 on the same day.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 30, 2024.
• Following these transactions, Baird directly owns 751,243 shares of Class A Common Stock and 54,556 derivative securities.
• The stock option, initially representing the right to purchase 2,043,499 shares of Hims, Inc., was converted after a business combination in 2021 to represent the right to purchase 1,086,723 shares of Hims & Hers Health, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan. There's no indication of positive or negative sentiment towards the company's prospects.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future actions.

Comparison to Industry Standards

• Comparing Melissa Baird's transactions to those of other executives in similar telehealth companies would provide a better understanding of whether these actions are typical.
• For example, reviewing Form 4 filings of executives at Teladoc Health (TDOC) or Amwell (AMWL) could offer a benchmark for stock option exercises and sales.
• Analyzing the frequency and size of insider transactions relative to company performance and industry trends can provide valuable context.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the change in ownership, but the pre-arranged trading plan mitigates concerns about insider information driving the sales.
• Employees may be indirectly affected by the perceived sentiment of the COO's transactions, although the Rule 10b5-1 plan should reassure them.

Key Dates

Keywords

Form 4, insider trading, stock options, HIMS, Hims & Hers Health, Melissa Baird, Class A Common Stock, Rule 10b5-1